LifeStance Health LFST

Medical - Care Facilities, Healthcare

$12.93

+2.95%

Market cap: $4.9B
PE: 99.5×
Forward PE: n/m; not a meaningful number
Price to sales: 3.1×
EV/EBIT: 63.6×
Revenue, 12 months: $1.6B; +20% on a year ago
Net margin: 3.2%
Free cash flow yield: 3.5%

LifeStance Health trades at 99.5× trailing earnings. Revenue was $1.6B over the last twelve months, up 20% on a year earlier with a 3% net margin.

Charts

Financials

Income statement for LFST, by quarter
Income statement	Q3 FY23	Q4 FY23	Q1 FY24	Q2 FY24	Q3 FY24	Q4 FY24	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
	$262.9M+21%	$280.6M+22%	$300.4M+19%	$312.3M+20%	$312.7M+19%	$325.5M+16%	$333M+11%	$345.3M+11%	$363.8M+16%	$382.2M+17%	$403.5M+21%	$435.4M+26%
SG&A	$130.9M+61%	$93.4M+4%	$88.9M+5%	$95.2M−7%	$85.3M−35%	$93.7M+0%	$94.4M+6%	$97.4M+2%	$95.6M+12%	$94.8M+1%	$100.3M+6%	$108.1M+11%
	−$74.4M+91%	−$32.3M−30%	−$16.8M−51%	−$15.9M−67%	$47K	$1.1M	$1.6M	−$3M−82%	$7.4M+15666%	$18.1M+1608%	$22.3M+1289%	$30.7M
Interest expense	$5.5M+31%	$5.5M+7%	$5.9M+16%	$5.8M+14%	$5.4M−1%	$9.4M+70%	$3.1M−48%	$2.9M−50%	$2.8M−48%	$2.9M−69%	$1.8M−42%	$2.6M−9%
Pre-tax income	−$78M+85%	−$38.3M−29%	−$20.7M−46%	−$22.6M−57%	−$5.4M−93%	−$8.9M−77%	−$1.5M−93%	−$5.9M−74%	$4.6M	$15.2M	$19.8M	$27.5M
	−$16.4M+276%	$6.6M	$363K	$656K	$575K	−$1.8M	−$2.2M	−$2.2M	$3.5M+508%	$3.5M	$5.5M	$3.8M
Net income	−$61.6M+63%	−$45M−4%	−$21.1M−38%	−$23.3M−49%	−$6M−90%	−$7.1M−84%	$709K	−$3.8M−84%	$1.1M	$11.7M	$14.2M+1909%	$23.6M
	−$0.17+55%	−$0.12−8%	−$0.06−33%	−$0.06−54%	−$0.02−88%	−$0.02−83%	$0.00	−$0.01−83%	$0.00	$0.03	$0.04	$0.06
	372.5M+4%	373.1M+4%	376.3M+4%	379.4M+5%	380.4M+2%	380.4M+2%	390.7M+4%	386.7M+2%	388.9M+2%	392.2M+3%	395.1M+1%	387.3M+0%

Revenue: Q1 FY21: 6 months less the 3 months printed beside them.

SG&A: Q1 FY21: 6 months less the 3 months printed beside them.

Operating income: Q1 FY21: 6 months less the 3 months printed beside them.

Interest expense: Q1 FY21: 6 months less the 3 months printed beside them.

Pre-tax income: Q1 FY21: 6 months less the 3 months printed beside them.

Net income: 7 periods, Q3 FY20 to Q2 FY22: not printed by the filing, worked out from its own lines. Q1 FY21: 6 months less the 3 months printed beside them.

EPS, diluted: 7 periods, Q4 FY20 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: Q4 FY20: a loss quarter: its basic count, share-days: the 9-month average less the 6-month, weighted by days. 3 periods, Q4 FY21 to Q4 FY24: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. 3 periods, Q2 FY22 to Q4 FY22: not printed by the filing, worked out from its own lines. Q4 FY25: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Care Facilities nearest LifeStance Health's size, closest first.

Company	Market cap	PE	Its 10y median PE	P/S	Revenue growth	Net margin
LFSTLifeStance Health	$4.9B	99.5×	142×	3.1×	+20%	3.2%
CONConcentra Group Holdings Parent	$5B	25.5×	17.5×	2.2×	+14%	8.7%
SHCSotera Health	$5.2B	31.8×	55.4×	4.2×	+8%	13.4%
OPCHOption Care Health	$4.7B	23.5×	26.4×	0.8×	+6%	3.7%
NHCNational Healthcare	$3.7B	26.5×	21.4×	2.4×	+7%	9.0%
CHEChemed	$6.7B	25.8×	29.0×	2.6×	+3%	10.6%
PACSPACS	$7.5B	27.2×	27.2×	1.4×	+15%	4.8%
AVAHAveanna Healthcare	$2.9B	10.9×	21.8×	1.1×	+20%	10.6%
PRVAPrivia Health	$2.9B	107×	158×	1.2×	+24%	1.2%
ENSGEnsign	$10.2B	27.5×	25.5×	1.9×	+19%	6.9%
MDPediatrix Medical	$2.4B	14.0×	13.4×	1.2×	+1%	9.0%
Peer median	$4.8B	26.1×	26.0×	1.6×	+11%	8.8%